Fig. 1From: Application of patient-derived induced pluripotent stem cells and organoids in inherited retinal diseasesFuture trends in the application of patient iPSC-derived ROs. Human organoid technology can be used for disease modeling, in-depth analysis of retinal pathogenesis in combination with multi-omics data, or biomimetic construction of retinal tissue in combination with 3D bioprinting and microfluidic chipsBack to article page